You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
金斯瑞生物科技(01548.HK):鎮江高新擬2.92億港元認購Probio Cayman 5731.4萬股B類優先股
格隆匯 07-04 07:33

格隆匯7月4日丨金斯瑞生物科技(01548.HK)發佈公吿,2022年7月2日,Probio Cayman訂立認購協議,據此,Probio Cayman同意於完成時發行及出售而B輪投資者(即鎮江高新創業投資(香港)有限公司)同意購買合共5731.4萬股B類優先股,總代價為3725.41萬美元(相當於約2.92億港元)。

根據披露,鎮江高新為於2010年6月根據中國法律成立的有限公司及江蘇瀚瑞投資控股有限公司的全資附屬公司,江蘇瀚瑞投資控股有限公司為由中國鎮江市人民政府全資擁有的國有企業。鎮江高新為加快鎮江經濟開發區轉型升級並提升產業競爭力,以及支持科技型中小企業產業化和新興產業發展的投資平台。

Probio Cayman為公司的間接非全資附屬公司,Probio集團提供抗體藥物發現、生物製劑臨牀前開發、生物製劑臨牀及商業生產、臨牀前至商業生產階段治療用質粒及病毒開發等四大類綜合CDMO服務。該等服務及相關產品助力生物製藥及生物技術公司從藥物發現到商業生產階段,加速在綜合平台開發生物製劑、細胞療法、基因療法、mRNA等。

緊接完成前,Probio Cayman由Probio BVI擁有約82.95%。緊隨完成後,Probio Cayman由 Probio BVI擁有約80.34%,未計及日後配發、發行及歸屬僱員股份擁有權計劃股份,並假設Probio認股權證未獲行使,及可換股債券未轉換成Probio股份。Probio Cayman將繼續為公司的間接非全資附屬公司。認購事項的所得款項擬用於滿足Probio Cayman的主要業務經營的資本開支及其他一般營運資金需求。公司相信,認購事項將為提高良好生產規範(GMP)產能與Probio Cayman發展現有業務的研發實力提供額外資金來源。 

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account